LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 49 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,247,353 | +2.1% | 1,256,000 | 0.0% | 1.18% | -13.2% |
Q4 2022 | $1,222,245 | +0.3% | 1,256,000 | 0.0% | 1.36% | -14.5% |
Q3 2022 | $1,219,000 | +4.7% | 1,256,000 | +3.5% | 1.60% | +1.7% |
Q2 2022 | $1,164,000 | -0.9% | 1,214,000 | +0.8% | 1.57% | +15.2% |
Q1 2022 | $1,174,000 | +45.7% | 1,204,000 | +148542.0% | 1.36% | +57.6% |
Q4 2021 | $806,000 | +0.5% | 810 | 0.0% | 0.86% | -31.9% |
Q3 2021 | $802,000 | +0.1% | 810 | 0.0% | 1.27% | +26.7% |
Q2 2021 | $801,000 | +88.9% | 810 | -99.8% | 1.00% | +109.0% |
Q1 2021 | $424,000 | -32.3% | 410,000 | -38.3% | 0.48% | -13.4% |
Q4 2020 | $626,000 | +12.8% | 665,000 | +8.1% | 0.55% | -29.4% |
Q3 2020 | $555,000 | – | 615,000 | – | 0.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |